Traversing the Path from Bench to Cancer Biomarker Validation

Recombinant antibodies and rigorous validation standards are advancing cancer biomarker research, bridging the gap between early discovery and clinical  translation.

Traversing the Path from Bench to Cancer Biomarker Validation cover image
cdc-CfS6A4U5g8M-unsplash

The Importance of Antibody Validation

Antibodies are a core reagent for many cancer biomarker assays, including IHC and enzyme-linked immunosorbent assays (ELISAs), and recombinant antibodies are another key tool for improving validation.

Read more

Want More? Subscribe to Our Blog Here!